Gilead Sciences Gross Margin 2012-2025 | GILD

Current and historical gross margin for Gilead Sciences (GILD) over the last 10 years. The current gross profit margin for Gilead Sciences as of September 30, 2025 is %.
Gilead Sciences Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-09-30 $29.09B $22.90B 78.72%
2025-06-30 $28.86B $22.67B 78.53%
2025-03-31 $28.74B $22.50B 78.29%
2024-12-31 $28.75B $22.50B 78.26%
2024-09-30 $28.30B $21.54B 76.11%
2024-06-30 $27.81B $21.05B 75.72%
2024-03-31 $27.45B $20.80B 75.78%
2023-12-31 $27.12B $20.62B 76.04%
2023-09-30 $27.39B $21.59B 78.81%
2023-06-30 $27.38B $21.75B 79.42%
2023-03-31 $27.04B $21.41B 79.17%
2022-12-31 $27.28B $21.62B 79.26%
2022-09-30 $27.14B $20.25B 74.62%
2022-06-30 $27.52B $20.80B 75.59%
2022-03-31 $27.47B $20.81B 75.74%
2021-12-31 $27.31B $20.70B 75.82%
2021-09-30 $27.48B $22.11B 80.45%
2021-06-30 $26.64B $21.35B 80.14%
2021-03-31 $25.56B $20.60B 80.58%
2020-12-31 $24.69B $20.12B 81.48%
2020-09-30 $23.15B $18.29B 79.02%
2020-06-30 $22.17B $17.42B 78.57%
2020-03-31 $22.72B $18.03B 79.37%
2019-12-31 $22.45B $17.77B 79.18%
2019-09-30 $22.37B $17.80B 79.60%
2019-06-30 $22.36B $17.74B 79.37%
2019-03-31 $22.32B $17.51B 78.45%
2018-12-31 $22.13B $17.27B 78.07%
2018-09-30 $22.28B $17.74B 79.63%
2018-06-30 $23.20B $18.71B 80.67%
2018-03-31 $24.69B $20.28B 82.12%
2017-12-31 $26.11B $21.74B 83.26%
2017-09-30 $27.48B $23.29B 84.75%
2017-06-30 $28.47B $24.18B 84.94%
2017-03-31 $29.10B $25.08B 86.17%
2016-12-31 $30.39B $26.13B 85.98%
2016-09-30 $31.58B $27.33B 86.55%
2016-06-30 $32.37B $28.19B 87.08%
2016-03-31 $32.84B $28.52B 86.85%
2015-12-31 $32.64B $28.63B 87.73%
2015-09-30 $31.45B $27.44B 87.26%
2015-06-30 $29.19B $25.26B 86.54%
2015-03-31 $27.49B $23.63B 85.97%
2014-12-31 $24.89B $21.10B 84.78%
2014-09-30 $20.70B $17.11B 82.69%
2014-06-30 $17.44B $14.16B 81.20%
2014-03-31 $13.67B $10.63B 77.78%
2013-12-31 $11.20B $8.34B 74.48%
2013-09-30 $10.67B $7.99B 74.91%
2013-06-30 $10.31B $7.72B 74.86%
2013-03-31 $9.95B $7.43B 74.62%
2012-12-31 $9.70B $7.23B 74.53%
2012-09-30 $9.31B $6.94B 74.46%
2012-06-30 $9.01B $6.70B 74.33%
2012-03-31 $8.74B $6.51B 74.49%
2011-12-31 $8.39B $6.26B 74.67%
2011-09-30 $8.18B $6.15B 75.11%
2011-06-30 $8.00B $6.02B 75.21%
2011-03-31 $7.79B $5.89B 75.56%
2010-12-31 $7.95B $6.08B 76.47%
2010-09-30 $7.98B $6.14B 76.86%
2010-06-30 $7.85B $6.07B 77.34%
2010-03-31 $7.57B $5.86B 77.45%
2009-12-31 $7.01B $5.42B 77.26%
2009-09-30 $6.41B $4.96B 77.49%
2009-06-30 $5.98B $4.64B 77.69%
2009-03-31 $5.61B $4.39B 78.31%
2008-12-31 $5.34B $4.21B 78.88%
2008-09-30 $5.00B $3.98B 79.57%
2008-06-30 $4.69B $3.77B 80.36%
2008-03-31 $4.46B $3.62B 81.21%
2007-12-31 $4.23B $3.46B 81.82%
2007-09-30 $4.03B $3.33B 82.45%
2007-06-30 $3.72B $3.11B 83.38%
2007-03-31 $3.36B $2.85B 84.71%
2006-12-31 $3.03B $2.59B 85.69%
2006-09-30 $2.74B $2.38B 87.13%
2006-06-30 $2.48B $2.17B 87.62%
2006-03-31 $2.29B $2.00B 87.25%
2005-12-31 $2.03B $1.77B 87.22%
2005-09-30 $1.79B $1.55B 86.91%
2005-06-30 $1.62B $1.41B 87.05%
2005-03-31 $1.45B $1.26B 86.93%
2004-12-31 $1.33B $1.16B 87.40%
2004-09-30 $1.22B $1.07B 87.53%
2004-06-30 $1.09B $0.96B 87.47%
2004-03-31 $1.01B $0.89B 87.45%
2003-12-31 $0.87B $0.76B 86.98%
2003-09-30 $0.75B $0.65B 86.78%
2003-06-30 $0.68B $0.59B 86.38%
2003-03-31 $0.55B $0.48B 85.90%
2002-12-31 $0.47B $0.40B 85.19%
2002-09-30 $0.40B $0.33B 84.30%
2002-06-30 $0.31B $0.26B 83.65%
2002-03-31 $0.25B $0.21B 82.28%
2001-12-31 $0.23B $0.19B 81.20%
2001-09-30 $0.21B $0.17B 82.08%
2001-06-30 $0.21B $0.17B 81.55%
2001-03-31 $0.21B $0.17B 82.44%
2000-12-31 $0.20B $0.16B 83.08%
2000-09-30 $0.19B $0.14B 75.00%
2000-06-30 $0.19B $0.14B 75.14%
2000-03-31 $0.14B $0.11B 74.31%
1999-12-31 $0.10B $0.07B 71.29%
1999-09-30 $0.06B $0.05B 88.52%
1999-06-30 $0.06B $0.06B 100.00%
1999-03-31 $0.05B $0.05B 100.00%
1998-12-31 $0.06B $0.06B 98.39%
1998-09-30 $0.06B $0.06B 98.41%
1998-06-30 $0.04B $0.04B 97.22%
1998-03-31 $0.05B $0.05B 95.92%
1997-12-31 $0.04B $0.04B 97.50%
1997-09-30 $0.04B $0.03B 94.44%
1997-06-30 $0.06B $0.05B 94.64%
1997-03-31 $0.04B $0.04B 94.74%
1996-12-31 $0.03B $0.03B 94.12%
1996-09-30 $0.03B $0.03B 96.55%
1996-06-30 $0.01B $0.01B 100.00%
1996-03-31 $0.00B $0.00B 100.00%
1995-12-31 $0.00B $0.02B 450.00%
1995-09-30 $0.00B $0.02B 450.00%
1995-06-30 $0.01B $0.01B 220.00%
1995-03-31 $0.01B $0.00B 80.00%
1994-12-31 $0.01B $-0.02B -460.00%
1994-09-30 $0.01B $-0.03B -600.00%
1994-06-30 $0.00B $-0.03B -725.00%
1994-03-31 $0.00B $-0.02B -550.00%
1993-12-31 $0.00B $-0.02B -500.00%
1993-09-30 $0.00B $-0.01B -325.00%
1993-06-30 $0.00B $-0.01B -275.00%
1993-03-31 $0.00B $-0.01B -350.00%
1992-12-31 $0.00B $0.00B -75.00%
1992-09-30 $0.00B $0.00B -75.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $150.246B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $293.552B 20.71
Amgen (AMGN) United States $175.599B 14.91
Vertex Pharmaceuticals (VRTX) United States $117.690B 30.30
Bristol Myers Squibb (BMY) United States $113.717B 8.52
GSK (GSK) United Kingdom $102.715B 11.38
Regeneron Pharmaceuticals (REGN) United States $83.717B 21.72
CSL (CSLLY) Australia $56.792B 0.00
Alnylam Pharmaceuticals (ALNY) United States $52.620B 1731.69
Argenex SE (ARGX) Netherlands $48.546B 60.28
Insmed (INSM) United States $37.530B 0.00
Biogen (BIIB) United States $27.524B 11.21
Royalty Pharma (RPRX) United States $23.188B 8.89
Revolution Medicines (RVMD) United States $22.935B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $22.643B 0.00
BioNTech SE (BNTX) Germany $22.484B 0.00
Genmab (GNMSF) Denmark $22.465B 16.48
Genmab (GMAB) Denmark $22.008B 16.55
Illumina (ILMN) United States $21.556B 32.36
Incyte (INCY) United States $20.981B 20.09
Exact Sciences (EXAS) United States $19.347B 537.42
Roivant Sciences (ROIV) United Kingdom $15.287B 0.00
Guardant Health (GH) United States $13.886B 0.00
Moderna (MRNA) United States $13.402B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $13.024B 24.23
Ascendis Pharma (ASND) Denmark $12.581B 0.00
Exelixis (EXEL) United States $11.808B 18.90
BioMarin Pharmaceutical (BMRN) United States $11.325B 20.54
Avidity Biosciences (RNA) United States $10.904B 0.00
Bio-Techne Corp (TECH) United States $10.237B 38.20
QIAGEN (QGEN) Netherlands $10.198B 19.36
Jazz Pharmaceuticals (JAZZ) Ireland $9.791B 38.18
Repligen (RGEN) United States $9.390B 100.49
Abivax SA (ABVX) France $8.915B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.772B 0.00
Axsome Therapeutics (AXSM) United States $8.539B 0.00
Halozyme Therapeutics (HALO) United States $8.522B 13.62
Bio-Rad Laboratories (BIO.B) United States $8.381B 30.14
Cytokinetics (CYTK) United States $7.643B 0.00
Nuvalent (NUVL) United States $7.638B 0.00
Krystal Biotech (KRYS) United States $7.580B 39.19
Praxis Precision Medicines (PRAX) United States $7.268B 0.00
Cidara Therapeutics (CDTX) United States $6.960B 0.00
Merus (MRUS) Netherlands $6.826B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.742B 0.00
PTC Therapeutics (PTCT) United States $6.225B 8.45
Vaxcyte (PCVX) United States $6.028B 0.00
Belite Bio (BLTE) United States $5.941B 0.00
Kymera Therapeutics (KYMR) United States $5.380B 0.00
Apogee Therapeutics (APGE) United States $5.328B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.131B 0.00
Anbio Biotechnology (NNNN) Germany $5.035B 0.00
Cogent Biosciences (COGT) United States $5.033B 0.00
Protagonist Therapeutics (PTGX) United States $5.015B 129.39
Celcuity (CELC) United States $4.975B 0.00
Alkermes (ALKS) Ireland $4.897B 14.40
Zealand Pharma (ZLDPF) Denmark $4.676B 4.74
Immunovant (IMVT) United States $4.562B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.531B 38.26
TG Therapeutics (TGTX) United States $4.520B 10.24
Akero Therapeutics (AKRO) United States $4.499B 0.00
Mirum Pharmaceuticals (MIRM) United States $4.449B 0.00
Amicus Therapeutics (FOLD) United States $4.406B 357.00
CG Oncology (CGON) United States $4.372B 0.00
Legend Biotech (LEGN) United States $4.359B 0.00
Scholar Rock Holding (SRRK) United States $4.303B 0.00
ADMA Biologics Inc (ADMA) United States $4.272B 30.42
Structure Therapeutics (GPCR) United States $4.163B 0.00
Ligand Pharmaceuticals (LGND) United States $4.067B 99.83
GRAIL (GRAL) United States $3.902B 0.00
Arcellx (ACLX) United States $3.832B 0.00
Viking Therapeutics (VKTX) United States $3.616B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.457B 0.00
Apellis Pharmaceuticals (APLS) United States $3.454B 88.07
IDEAYA Biosciences (IDYA) United States $3.277B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.263B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.257B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.234B 94.82
Terns Pharmaceuticals (TERN) United States $3.196B 0.00
Liquidia (LQDA) United States $3.120B 0.00
Vera Therapeutics (VERA) United States $3.114B 0.00
Travere Therapeutics (TVTX) United States $3.094B 0.00
Viridian Therapeutics (VRDN) United States $3.030B 0.00
Disc Medicine (IRON) United States $2.950B 0.00
Beam Therapeutics (BEAM) United States $2.796B 0.00
Nuvation Bio (NUVB) United States $2.756B 0.00
Mesoblast (MESO) Australia $2.689B 0.00
Ascentage Pharma Group - (AAPG) China $2.686B 0.00
Mineralys Therapeutics (MLYS) United States $2.641B 0.00
Edgewise Therapeutics (EWTX) United States $2.636B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.568B 0.00
Telix Pharmaceuticals (TLX) Australia $2.561B 0.00
Denali Therapeutics (DNLI) United States $2.505B 0.00
Sarepta Therapeutics (SRPT) United States $2.497B 0.00
Bavarian Nordic (BVNRY) Denmark $2.451B 6.65
Recursion Pharmaceuticals (RXRX) United States $2.422B 0.00
Adaptive Biotechnologies (ADPT) United States $2.406B 0.00
Spyre Therapeutics (SYRE) United States $2.375B 0.00
WAVE Life Sciences (WVE) Singapore $2.314B 0.00
ImmunityBio (IBRX) United States $2.295B 0.00
Arcus Biosciences (RCUS) United States $2.269B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.220B 12.12
Ultragenyx Pharmaceutical (RARE) United States $2.172B 0.00
Twist Bioscience (TWST) United States $2.164B 0.00
Zai Lab (ZLAB) China $2.077B 0.00
Alumis (ALMS) United States $2.042B 0.00
Vericel (VCEL) United States $1.950B 160.67
Maze Therapeutics (MAZE) United States $1.940B 0.00
Immunome (IMNM) United States $1.932B 0.00
Olema Pharmaceuticals (OLMA) United States $1.928B 0.00
Erasca (ERAS) United States $1.918B 0.00
Stoke Therapeutics (STOK) United States $1.876B 49.03
Syndax Pharmaceuticals (SNDX) United States $1.825B 0.00
Celldex Therapeutics (CLDX) United States $1.819B 0.00
Dynavax Technologies (DVAX) United States $1.810B 53.14
MannKind (MNKD) United States $1.796B 58.50
Sionna Therapeutics (SION) United States $1.752B 0.00
Zymeworks (ZYME) United States $1.734B 0.00
ANI Pharmaceuticals (ANIP) United States $1.714B 13.29
NeoGenomics (NEO) United States $1.703B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.668B 0.00
Agios Pharmaceuticals (AGIO) United States $1.657B 0.00
Dianthus Therapeutics (DNTH) United States $1.637B 0.00
Precigen (PGEN) United States $1.624B 0.00
Upstream Bio (UPB) United States $1.608B 0.00
NovoCure (NVCR) Jersey $1.607B 0.00
Fortrea Holdings (FTRE) United States $1.607B 34.10
Tango Therapeutics (TNGX) United States $1.582B 0.00
Monte Rosa Therapeutics (GLUE) United States $1.581B 75.88
UniQure (QURE) Netherlands $1.577B 0.00
Tyra Biosciences (TYRA) United States $1.564B 0.00
Certara (CERT) United States $1.486B 27.44
Nurix Therapeutics (NRIX) United States $1.484B 0.00
Kodiak Sciences (KOD) United States $1.471B 0.00
Trevi Therapeutics (TRVI) United States $1.434B 0.00
MBX Biosciences (MBX) United States $1.422B 0.00
Alvotech (ALVO) Luxembourg $1.399B 20.17
Rapport Therapeutics (RAPP) United States $1.380B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.363B 0.00
AtaiBeckley Inc (ATAI) Netherlands $1.362B 0.00
Pharvaris (PHVS) Netherlands $1.354B 0.00
EyePoint (EYPT) United States $1.344B 0.00
AbCellera Biologics (ABCL) Canada $1.308B 0.00
Pharming Group (PHAR) Netherlands $1.282B 0.00
AnaptysBio (ANAB) United States $1.237B 0.00
Sana Biotechnology (SANA) United States $1.215B 0.00
Oculis Holding AG (OCS) Switzerland $1.208B 0.00
Intellia Therapeutics (NTLA) United States $1.202B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $1.188B 0.00
Novavax (NVAX) United States $1.181B 3.00
Biohaven (BHVN) United States $1.176B 0.00
Castle Biosciences (CSTL) United States $1.148B 157.36
Septerna (SEPN) United States $1.133B 0.00
Immatics (IMTX) Germany $1.115B 0.00
Pharming Group (PHGUF) Netherlands $1.107B 165.00
Palvella Therapeutics (PVLA) United States $1.094B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.072B 0.00
Inhibrx Biosciences (INBX) United States $1.060B 0.00
Oxford BioMedica (OXBDF) United Kingdom $1.058B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $1.055B 0.00
Pacira BioSciences (PCRX) United States $1.012B 11.59
Urogen Pharma (URGN) United States $0.995B 0.00
Nanobiotix S.A - (NBTX) France $0.994B 0.00
Ventyx Biosciences (VTYX) United States $0.985B 0.00
Bicara Therapeutics (BCAX) United States $0.983B 0.00
Iovance Biotherapeutics (IOVA) United States $0.973B 0.00
Compass Therapeutics (CMPX) United States $0.952B 0.00
Rapt Therapeutics (RAPT) United States $0.932B 0.00
CureVac (CVAC) Germany $0.927B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.918B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.908B 0.00
MiMedx (MDXG) United States $0.903B 16.05
Oric Pharmaceuticals (ORIC) United States $0.891B 0.00
Arbutus Biopharma (ABUS) United States $0.889B 0.00
YD Bio (YDES) $0.870B 0.00
Zenas BioPharma (ZBIO) United States $0.863B 0.00
Geron (GERN) United States $0.855B 0.00
Janux Therapeutics (JANX) United States $0.852B 0.00
ArriVent BioPharma (AVBP) United States $0.847B 0.00
Kura Oncology (KURA) United States $0.819B 0.00
MapLight Therapeutics (MPLT) United States $0.818B 0.00
Vir Biotechnology (VIR) United States $0.814B 0.00
GH Research (GHRS) Ireland $0.781B 0.00
Arvinas (ARVN) United States $0.775B 0.00
REGENXBIO (RGNX) United States $0.739B 0.00
CytomX Therapeutics (CTMX) United States $0.737B 10.88
Astria Therapeutics (ATXS) United States $0.735B 0.00
Gyre Therapeutics (GYRE) United States $0.713B 92.50
Prime Medicine (PRME) United States $0.711B 0.00
Inventiva S.A (IVA) France $0.705B 0.00
Cytek Biosciences (CTKB) United States $0.697B 0.00
DBV Technologies S.A (DBVT) France $0.683B 0.00
Emergent Biosolutions (EBS) United States $0.681B 6.55
Bright Minds Biosciences (DRUG) United States $0.675B 0.00
Jade Biosciences (JBIO) United States $0.667B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Cullinan Therapeutics (CGEM) United States $0.644B 0.00
Evommune (EVMN) United States $0.635B 0.00
Replimune (REPL) United States $0.630B 0.00
Annexon (ANNX) United States $0.628B 0.00
Myriad Genetics (MYGN) United States $0.613B 0.00
CorMedix Inc (CRMD) United States $0.601B 5.57
MeiraGTx Holdings (MGTX) United States $0.596B 0.00
EnGene Holdings (ENGN) Canada $0.590B 0.00
Invivyd (IVVD) United States $0.587B 0.00
Keros Therapeutics (KROS) United States $0.585B 12.47
Gossamer Bio (GOSS) United States $0.579B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.560B 0.00
Design Therapeutics (DSGN) United States $0.535B 0.00
Fulcrum Therapeutics (FULC) United States $0.533B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.524B 0.00
Niagen Bioscience (NAGE) United States $0.520B 40.75
Verastem (VSTM) United States $0.520B 0.00
Alto Neuroscience (ANRO) United States $0.509B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.507B 0.00
BioAge Labs (BIOA) United States $0.503B 0.00
Absci (ABSI) United States $0.501B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
SELLAS Life Sciences (SLS) United States $0.493B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.482B 0.00
Ocugen (OCGN) United States $0.468B 0.00
LENZ Therapeutics (LENZ) United States $0.465B 0.00
Kamada (KMDA) Israel $0.462B 22.33
Bicycle Therapeutics (BCYC) United Kingdom $0.461B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.453B 0.00
PepGen (PEPG) United States $0.445B 0.00
Prima BioMed (IMMP) Australia $0.435B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.433B 0.00
NovaBridge Biosciences (NBP) United States $0.427B 0.00
PureTech Health (PRTC) United States $0.425B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.425B 0.00
DiaMedica Therapeutics (DMAC) United States $0.425B 0.00
Monopar Therapeutics (MNPR) United States $0.421B 0.00
Eton Pharmaceuticals (ETON) United States $0.415B 0.00
Northwest Biotherapeutics (NWBO) United States $0.413B 0.00
Solid Biosciences (SLDB) United States $0.412B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.404B 0.00
Benitec Biopharma (BNTC) United States $0.401B 0.00
BGM Group (BGM) China $0.387B 0.00
Tectonic Therapeutic (TECX) United States $0.385B 0.00
Allogene Therapeutics (ALLO) United States $0.384B 0.00
Entrada Therapeutics (TRDA) United States $0.383B 0.00
Anavex Life Sciences (AVXL) United States $0.382B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.378B 0.00
Neumora Therapeutics (NMRA) United States $0.371B 0.00
XOMA Royalty (XOMA) United States $0.370B 0.00
Kyverna Therapeutics (KYTX) United States $0.364B 0.00
Greenwich LifeSciences (GLSI) United States $0.350B 0.00
X4 Pharmaceuticals (XFOR) United States $0.350B 0.00
Climb Bio (CLYM) United States $0.343B 0.00
AC Immune (ACIU) Switzerland $0.342B 0.00
Zura Bio (ZURA) United States $0.333B 0.00
Amarin (AMRN) Ireland $0.329B 0.00
Aura Biosciences (AURA) United States $0.323B 0.00
Candel Therapeutics (CADL) United States $0.313B 0.00
Aardvark Therapeutics (AARD) United States $0.311B 0.00
Puma Biotechnology (PBYI) United States $0.308B 8.26
GENFIT S.A (GNFTY) France $0.303B 0.00
Shattuck Labs (STTK) United States $0.301B 0.00
Immuneering (IMRX) United States $0.301B 0.00
Forte Biosciences (FBRX) United States $0.299B 0.00
Palisade Bio (PALI) United States $0.297B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.292B 0.00
Foghorn Therapeutics (FHTX) United States $0.292B 0.00
Jyong Biotech (MENS) Taiwan $0.290B 0.00
Lifecore Biomedical (LFCR) United States $0.283B 0.00
Abeona Therapeutics (ABEO) United States $0.281B 4.59
CAMP4 Therapeutics (CAMP) United States $0.278B 0.00
Neurogene (NGNE) United States $0.278B 0.00
Contineum Therapeutics (CTNM) United States $0.272B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.271B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.270B 0.00
Adherex Technologies (FENC) United States $0.265B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.261B 0.00
Nautilus Biotechnology (NAUT) United States $0.260B 0.00
Rezolute (RZLT) United States $0.244B 0.00
Adocia (ADOCY) France $0.231B 0.00
Alpha Teknova (TKNO) United States $0.224B 0.00
Voyager Therapeutics (VYGR) United States $0.224B 0.00
Humacyte (HUMA) United States $0.219B 0.00
Nuvectis Pharma (NVCT) United States $0.217B 0.00
Cartesian Therapeutics (RNAC) United States $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.207B 0.00
C4 Therapeutics (CCCC) United States $0.207B 0.00
Coherus Oncology (CHRS) United States $0.204B 0.00
Alector (ALEC) United States $0.203B 0.00
Cabaletta Bio (CABA) United States $0.202B 0.00
Editas Medicine (EDIT) United States $0.202B 0.00
Sagimet Biosciences (SGMT) United States $0.202B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.193B 0.00
Cybin (HELP) Canada $0.190B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.186B 0.00
Kalaris Therapeutics (KLRS) United States $0.183B 0.00
SAB Biotherapeutics (SABS) United States $0.175B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.174B 0.00
Rani Therapeutics Holdings (RANI) United States $0.170B 0.00
Compugen (CGEN) Israel $0.168B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.167B 0.00
Molecular Partners AG (MOLN) Switzerland $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.165B 0.00
Immix Biopharma (IMMX) United States $0.164B 0.00
Black Diamond Therapeutics (BDTX) United States $0.160B 7.81
Caribou Biosciences (CRBU) United States $0.155B 0.00
MaxCyte (MXCT) United States $0.153B 0.00
Crescent Biopharma (CBIO) United States $0.150B 0.00
Quince Therapeutics (QNCX) United States $0.150B 0.00
Sangamo Therapeutics (SGMO) United States $0.149B 0.00
Nkarta (NKTX) United States $0.148B 0.00
Codexis (CDXS) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.144B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Alpha Cognition (ACOG) Canada $0.142B 0.00
Seres Therapeutics (MCRB) United States $0.142B 0.00
Elicio Therapeutics (ELTX) United States $0.141B 0.00
Vor Biopharma (VOR) $0.141B 0.00
VTv Therapeutics (VTVT) United States $0.140B 0.00
Anika Therapeutics (ANIK) United States $0.137B 0.00
Turn Therapeutics (TTRX) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Opus Genetics (IRD) United States $0.133B 0.00
Agenus (AGEN) United States $0.133B 0.00
Tenaya Therapeutics (TNYA) United States $0.127B 0.00
Cognition Therapeutics (CGTX) United States $0.124B 0.00
Whitehawk Therapeutics (WHWK) United States $0.124B 0.00
Fate Therapeutics (FATE) United States $0.121B 0.00
Connect Biopharma Holdings (CNTB) United States $0.120B 0.00
Artiva Biotherapeutics (ARTV) United States $0.119B 0.00
Ovid Therapeutics (OVID) United States $0.119B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.110B 0.00
Repare Therapeutics (RPTX) Canada $0.110B 0.00
Seer (SEER) United States $0.109B 0.00
Starpharma Holdings (SPHRY) Australia $0.109B 0.00
Scilex Holding (SCLX) United States $0.109B 0.00
Genelux (GNLX) United States $0.107B 0.00
Sutro Biopharma (STRO) United States $0.104B 0.00
Inovio Pharmaceuticals (INO) United States $0.104B 0.00
OKYO Pharma (OKYO) $0.104B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.103B 0.00
Tharimmune (THAR) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Biomea Fusion (BMEA) United States $0.100B 0.00
Atara Biotherapeutics (ATRA) United States $0.099B 6.27
Annovis Bio (ANVS) United States $0.097B 0.00
Chrome Holding (MEHCQ) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Citius Oncology (CTOR) United States $0.092B 0.00
Spruce Biosciences (SPRB) United States $0.086B 0.00
CalciMedica (CALC) United States $0.084B 0.00
BioStem Technologies (BSEM) $0.084B 5.88
Tenax Therapeutics (TENX) United States $0.083B 0.00
BioHarvest Sciences (BHST) Canada $0.082B 0.00
Pliant Therapeutics (PLRX) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.079B 0.00
XBiotech (XBIT) United States $0.078B 0.00
ImageneBio (IMA) United States $0.078B 0.00
Tevogen Bio Holdings (TVGN) United States $0.077B 0.00
Adicet Bio (ACET) United States $0.077B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.076B 0.00
MediciNova (MNOV) United States $0.075B 0.00
Entera Bio (ENTX) Israel $0.073B 0.00
ALX Oncology Holdings (ALXO) United States $0.073B 0.00
Adagene (ADAG) China $0.072B 0.00
CervoMed (CRVO) United States $0.072B 0.00
ATyr Pharma (ATYR) United States $0.070B 0.00
InflaRx (IFRX) Germany $0.070B 0.00
Equillium (EQ) United States $0.069B 0.00
TScan Therapeutics (TCRX) United States $0.069B 0.00
Clene (CLNN) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.064B 0.00
Passage Bio (PASG) United States $0.063B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.062B 0.00
Radiopharm Theranostics - (RADX) Australia $0.061B 0.00
IBio (IBIO) United States $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
MiNK Therapeutics (INKT) United States $0.058B 0.00
Grace Therapeutics (GRCE) United States $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.055B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.054B 0.00
ABVC BioPharma (ABVC) United States $0.053B 0.00
PDS Biotechnology (PDSB) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.052B 0.00
Instil Bio (TIL) United States $0.048B 0.00
NextCure (NXTC) United States $0.047B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.045B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
TELA Bio (TELA) United States $0.044B 0.00
BioXcel Therapeutics (BTAI) United States $0.044B 0.00
Tvardi Therapeutics (TVRD) United States $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Jasper Therapeutics (JSPR) United States $0.042B 0.00
RenovoRx (RNXT) United States $0.041B 0.00
IO Biotech (IOBT) Denmark $0.040B 0.00
INmune Bio (INMB) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
TuHURA Biosciences (HURA) United States $0.039B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Exicure (XCUR) United States $0.037B 0.00
Celularity (CELU) United States $0.037B 0.00
Generation Bio (GBIO) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Femasys (FEMY) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Galecto (GLTO) Denmark $0.033B 0.00
Skye Bioscience (SKYE) United States $0.031B 0.00
Cingulate (CING) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.031B 0.00
Elutia (ELUT) United States $0.031B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Rallybio (RLYB) United States $0.030B 0.00
Boundless Bio (BOLD) United States $0.029B 0.00
Werewolf Therapeutics (HOWL) United States $0.029B 0.00
Senti Biosciences (SNTI) United States $0.029B 0.00
Cue Biopharma (CUE) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.027B 0.00
Genenta Science S.p.A (GNTA) Italy $0.027B 0.00
Hyperion DeFi (HYPD) United States $0.027B 0.00
Aytu BioPharma (AYTU) United States $0.027B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
Quantum Biopharma (QNTM) Canada $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Apollomics (APLM) United States $0.024B 0.00
Neuphoria Therapeutics (NEUP) United States $0.023B 0.00
FibroBiologics (FBLG) United States $0.022B 0.00
Pasithea Therapeutics (KTTA) United States $0.022B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
MetaVia (MTVA) United States $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Bionano Genomics (BNGO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Applied Therapeutics (APLT) United States $0.015B 0.00
Black Titan (BTTC) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.015B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Polyrizon (PLRZ) Israel $0.013B 0.00
Longeveron (LGVN) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Imunon (IMNN) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Abpro Holdings (ABP) United States $0.011B 0.00
Curis (CRIS) United States $0.011B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
NewcelX (NCEL) Switzerland $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Alzamend Neuro (ALZN) United States $0.009B 0.00
Aptevo Therapeutics (APVO) United States $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Gelteq (GELS) Australia $0.008B 0.00
Advanced Biomed (ADVB) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Beyond Air (XAIR) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
KALA BIO (KALA) United States $0.006B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.006B 0.00
BioAffinity Technologies (BIAF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GeoVax Labs (GOVX) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.004B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.004B 0.00
HCW Biologics (HCWB) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Alps Group (ALPS) United States $0.003B 2.98
AquaBounty Technologies (AQB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Enveric Biosciences (ENVB) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00